Home > Cashflow Statement > WINDLAS BIOTECH

WINDLAS BIOTECH
Cash Flow from Financing Activities

    Back to Cashflow Statement
COMMUNITY POLL
for WINDLAS BIOTECH
Please provide your vote to see the results

WINDLAS BIOTECH Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Cash Flow from Financing Activities ₹-13 Cr₹1.01 Cr₹-15 Cr₹-44 Cr₹130 Cr

What is the latest Cash Flow from Financing Activities ratio of WINDLAS BIOTECH ?

The latest Cash Flow from Financing Activities ratio of WINDLAS BIOTECH is ₹-13 Cr based on Mar2026 Consolidated results.
Year Cash Flow from Financing Activities
Mar2026₹-13 Cr
Mar2025₹1.01 Cr
Mar2024₹-15 Cr
Mar2023₹-44 Cr
Mar2022₹130 Cr

How is Cash Flow from Financing Activities of WINDLAS BIOTECH Trending?

Years Cash Flow from Financing Activities % Change
Mar2026 ₹-13 Cr
Negative
Mar2025 ₹1.01 Cr
Positive
Mar2024 ₹-15 Cr
Negative
Mar2023 ₹-44 Cr
Negative
Mar2022 ₹130 Cr -

Compare Cash Flow from Financing Activities of peers of WINDLAS BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
WINDLAS BIOTECH ₹1,764.7 Cr -0.5% -0.3% -7.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹480,047.0 Cr 1.8% 6.8% 17.8% Stock Analytics
DIVIS LABORATORIES ₹208,141.0 Cr 6.7% 18.5% 12.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹185,264.0 Cr -3.7% 5.5% 39.8% Stock Analytics
CIPLA ₹118,430.0 Cr 5.7% 0.6% -1.4% Stock Analytics
DR REDDYS LABORATORIES ₹95,516.1 Cr -2% -15.8% -8.4% Stock Analytics


WINDLAS BIOTECH Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
WINDLAS BIOTECH

-0.5%

-0.3%

-7.2%

SENSEX

2%

1.9%

-5.2%


You may also like the below Video Courses